Literature DB >> 23307606

Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.

Jun-Jing Zhu1, Yi-Qiao Xu, Jian-Hui He, Hang-Ping Yu, Chang-Jiang Huang, Ji-Min Gao, Qiao-Xiang Dong, Yao-Xian Xuan, Chun-Qi Li.   

Abstract

Cardiovascular toxicity is a major challenge for the pharmaceutical industry and predictive screening models to identify and eliminate pharmaceuticals with the potential to cause cardiovascular toxicity in humans are urgently needed. In this study, taking advantage of the transparency of larval zebrafish, Danio rerio, we assessed cardiovascular toxicity of seven known human cardiotoxic drugs (aspirin, clomipramine hydrochloride, cyclophosphamide, nimodipine, quinidine, terfenadine and verapamil hydrochloride) and two non-cardiovascular toxicity drugs (gentamicin sulphate and tetracycline hydrochloride) in zebrafish using six specific phenotypic endpoints: heart rate, heart rhythm, pericardial edema, circulation, hemorrhage and thrombosis. All the tested drugs were delivered into zebrafish by direct soaking and yolk sac microinjection, respectively, and cardiovascular toxicity was quantitatively or qualitatively assessed at 4 and 24 h post drug treatment. The results showed that aspirin accelerated the zebrafish heart rate (tachycardia), whereas clomipramine hydrochloride, cyclophosphamide, nimodipine, quinidine, terfenadine and verapamil hydrochloride induced bradycardia. Quinidine and terfenadine also caused atrioventricular (AV) block. Nimodipine treatment resulted in atrial arrest with much slower but regular ventricular heart beating. All the tested human cardiotoxic drugs also induced pericardial edema and circulatory disturbance in zebrafish. There was no sign of cardiovascular toxicity in zebrafish treated with non-cardiotoxic drugs gentamicin sulphate and tetracycline hydrochloride. The overall prediction success rate for cardiotoxic drugs and non-cardiotoxic drugs in zebrafish were 100% (9/9) as compared with human results, suggesting that zebrafish is an excellent animal model for rapid in vivo cardiovascular toxicity screening. The procedures we developed in this report for assessing cardiovascular toxicity in zebrafish were suitable for drugs delivered by either soaking or microinjection.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  animal model; arrhythmia; cardiotoxicity; cardiovascular toxicity; drug screen; microinjection; toxicity assessment; zebrafish

Mesh:

Substances:

Year:  2013        PMID: 23307606     DOI: 10.1002/jat.2843

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  16 in total

1.  Zebrafish: A marvel of high-throughput biology for 21st century toxicology.

Authors:  Sean M Bugel; Robert L Tanguay; Antonio Planchart
Journal:  Curr Environ Health Rep       Date:  2014-09-07

2.  Protective Effects of Spermidine and Melatonin on Deltamethrin-Induced Cardiotoxicity and Neurotoxicity in Zebrafish.

Authors:  Xingyu Liu; Qian Gao; Zeyang Feng; Yaqiu Tang; Xin Zhao; Dongyan Chen; Xizeng Feng
Journal:  Cardiovasc Toxicol       Date:  2020-07-10       Impact factor: 3.231

3.  Clozapine Induced Developmental and Cardiac Toxicity on Zebrafish Embryos by Elevating Oxidative Stress.

Authors:  Feng Zhang; Liwen Han; Jiazhen Wang; Minglei Shu; Kechun Liu; Yun Zhang; ChungDer Hsiao; Qingping Tian; Qiuxia He
Journal:  Cardiovasc Toxicol       Date:  2021-01-24       Impact factor: 3.231

Review 4.  Zebrafish: An emerging whole-organism screening tool in safety pharmacology.

Authors:  Vandana S Nikam; Deeksha Singh; Rohan Takawale; Minal R Ghante
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

5.  Clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function.

Authors:  Jasmine L Hamilton; Azadeh Hatef; Muhammad Imran ul-Haq; Neelima Nair; Suraj Unniappan; Jayachandran N Kizhakkedathu
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

6.  In Vivo Cardiotoxicity Induced by Sodium Aescinate in Zebrafish Larvae.

Authors:  Jinfeng Liang; Wangdong Jin; Hongwen Li; Hongcui Liu; Yanfeng Huang; Xiaowen Shan; Chunqi Li; Letian Shan; Thomas Efferth
Journal:  Molecules       Date:  2016-02-23       Impact factor: 4.411

Review 7.  Zebrafish Heart Failure Models.

Authors:  Suneeta Narumanchi; Hong Wang; Sanni Perttunen; Ilkka Tikkanen; Päivi Lakkisto; Jere Paavola
Journal:  Front Cell Dev Biol       Date:  2021-05-20

8.  Novel Pyridyl-Oxazole Carboxamides: Toxicity Assay Determination in Fungi and Zebrafish Embryos.

Authors:  Shu Chen; Dong-Lin Zhang; Chao-Li Ren; Wen-Qian Zou; Xiao-Yu Tian; Xiao-Hua Du; Cheng-Xia Tan
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 9.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

10.  Screening and Identification of Cardioprotective Compounds From Wenxin Keli by Activity Index Approach and in vivo Zebrafish Model.

Authors:  Hao Liu; Xuechun Chen; Xiaoping Zhao; Buchang Zhao; Ke Qian; Yang Shi; Mirko Baruscotti; Yi Wang
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.